| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |